Acadia Pharmaceuticals (ACAD) EPS (Basic) (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted quarterly EPS (Basic) of $0.02 for Q1 2026, down 81.26% year-over-year from $0.11 in Q1 2025, and down 98.69% quarter-over-quarter from $1.62 in Q4 2025.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) EPS (Basic) (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' EPS (Basic) history runs 17 years deep, the most recent figure standing at $0.02 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 81.26% year-over-year to $0.02; the TTM figure through Mar 2026 stood at $2.2 (up 60.55% YoY), while the FY2025 annual figure was $2.32, up 69.96% from the prior year.
- EPS (Basic) for Q1 2026 stood at $0.02, down from $1.62 in the prior quarter.
- The five-year high for EPS (Basic) was $279.56 in Q4 2023, with the low at -$396.85 in Q3 2023.
- The 5-year median for EPS (Basic) is $0.11 (2025), against an average of -$43.74.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) tumbled 186442.28% in 2022, then soared 208.54% in 2023.
- Acadia Pharmaceuticals' EPS (Basic) stood at -$257.57 in 2022, then jumped by 208.54% to $279.56 in 2023, then slumped by 99.69% to $0.87 in 2024, then soared by 87.34% to $1.62 in 2025, then plunged by 98.69% to $0.02 in 2026.
- Business Quant data shows ACAD's EPS (Basic) at $0.02 in Q1 2026, $1.62 in Q4 2025, and $0.43 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Acadia Pharmaceuticals | 4.82 Bn | 3.86 Bn | 279.64 Mn | 0.18 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.18 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 1.62 |
| Sep 30, 2025 | 0.43 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | 0.87 |
| Sep 30, 2024 | 0.20 |
| Jun 30, 2024 | 0.20 |
| Mar 31, 2024 | 0.10 |
| Dec 31, 2023 | 0.28 |
| Sep 30, 2023 | -0.40 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | -0.27 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | -0.17 |
| Jun 30, 2022 | -0.21 |
| Mar 31, 2022 | -0.70 |
| Dec 31, 2021 | -0.05 |
| Sep 30, 2021 | -0.09 |